FIELD: medicine, physiotherapy. SUBSTANCE: method involves administration of preparation containing recombinant α2-interferon by inhalation route. Before its administration any physiotherapeutic procedure is used that dilutes sputum and/or improves its passage. Said method enhances bioavailability of preparation in region of upper and lower respiratory tract due to increase of relative concentration and exposition time in respiratory tracts. EFFECT: improved method of administration, enhanced availability. 2 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF LYMPHOADENOPATHY | 2002 |
|
RU2217146C2 |
METHOD FOR SANITATION OF GERM CARRIER RESPIRATORY WAY | 2003 |
|
RU2257223C2 |
ANTIVIRAL, ANTIBACTERIAL AND ANTICANDIDOSIS AGENT | 1999 |
|
RU2144832C1 |
BIOLOGICALLY ACTIVE FOOD ADDITION | 1998 |
|
RU2125389C1 |
FOOD BIOLOGICALLY ACTIVE ADDITION | 1999 |
|
RU2144294C1 |
METHOD OF TREATING PATIENTS WITH INFECTIOUS DISEASES | 1999 |
|
RU2146531C1 |
METHOD OF TREATING BRONCHOPULMONARY DISEASES | 2018 |
|
RU2695366C1 |
BIOLOGICALLY ACTIVE ADDITION | 2000 |
|
RU2164765C1 |
METHOD OF TREATMENT AND PREVENTION OF RECURRENT BRONCHITIS ASSOCIATED WITH IMPACT OF FINE DUST IN CHILDREN | 2018 |
|
RU2682116C1 |
METHOD OF PREVENTING INFLUENZA AND ACUTE RESPIRATORY INFECTIONS IN CHILDREN SUFFERING BRONCHIAL ASTHMA | 2011 |
|
RU2456020C1 |
Authors
Dates
2001-10-10—Published
1999-04-06—Filed